中文名稱:
克唑替尼
中文別名:
克里唑替尼;
克里唑啼尼;
3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺;
3-[(R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(哌啶-4-基)-1H-吡唑-4-基]吡啶-2-胺;
英文名稱:
Crizotinib
英文別名:
(R)-Crizotinib;
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine;
Xalkori;
CAS號:
877399-52-5
分子式:
C21H22Cl2FN5O
分子量:
450.33700
精確質(zhì)量:
449.11900
PSA:
77.99000
LogP:
5.94770
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children
武漢藥肽科技有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!